PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1201
https://www.valueinhealthjournal.com/article/S1098-3015(11)02763-X/fulltext
Title : PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02763-X&doi=10.1016/j.jval.2011.08.1201
First page : A452
Section Title : Cancer
Open access? : No
Section Order : 1158
Categories :
Tags :
Regions :
ViH Article Tags :